The age of the world population is increasing at an unprecedented rate. It is estimated that the number of persons over 65 years of age worldwide will grow from 500 million in 2008 to nearly 700 million in 2020. 1 Similar trend is expected in the population over 80 years of age. 2 The number of those over 80 in countries with large population particularly in the United States, India and China is striking. Even in Africa, where old age-related problem has not traditionally been well researched, the number of those over 80 years will be impressive ( Figure 1 ).
In addition to the impact on health, the increase in old age people has become a social, economical and political problem. The rise in old age people in developed countries is associated with almost a proportionate decrease in the work force and the cost of care is increasing at a time when resources are shrinking.
Little is known about the pathology of old age and many clinical trials using therapeutic agents exclude older population. Despite this, the size of the problem commands a need of an in-depth knowledge of interaction between diseases and aging and to require a positive interaction among health workers, local governments and politicians.
It is argued that old age by itself may be a disease with distinct symptoms (Table 1) . Despite this, studies show that the health of the population over 80 years is steadily improving. The rate of ischemic heart disease, heart failure and cerebrovascular disease is steadily falling. 3, 4 Old age people do not necessarily hold nihilistic views towards their health. Collerton et al. 5 collected data in a postal survey of over 1000 patients in Newcastle Upon Tyne. Many patients rated their health to be good or excellent.
The UK government has regarded aging to be a pressing problem for a long time now and have issued a service framework for the care of older people. 6 The document recommended a fresh and a more proactive approach to the clinical and social health of old people. Furthermore, many grant-giving bodies advocate research in old age to be a priority with the view of introducing therapeutic intervention as well as rehabilitation and prosthesis. 7 Respiratory diseases increase with old age and the current series will address disease-specific areas including airways disease, parenchymal disease and respiratory infections. A common denominator of lung disease in old age is the atypical presentation, uncertainty of the efficacy of pharmacological intervention and worse prognosis. In addition to the increase in prevalence of lung diseases in old age, the rate of their complications and mortality rate also increase when compared with young patients.
Physical impairment of old age itself makes the assessment of therapeutic intervention and the outcome for success of interventions different from those with respiratory disease in younger population. For example, improvement of mobility to achieve a degree of independence is a preferable outcome for the improvement of forced expiratory volume in the first second (FEV 1 ).
This ultimate aim of this series in chronic respiratory disease is to gain an understanding of the problem and to help designing better methods of approaching it.
Irrespective of the disease-specific area, a multidimensional and interdisciplinary intervention is probably required to tackle these diseases in an increasing old population. 
